Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT01606800
What this trial is testing

Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 45
Not applicableStudy completedNCT00772707
What this trial is testing

A Multi-Center Investigation of Patient Acceptability of OPTI-FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)

Who this might be right for
Myopia
Alcon Research 114
Large-scale testing (Phase 3)Study completedNCT01155700
What this trial is testing

Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)

Who this might be right for
Allergic Asthma
Novartis Pharmaceuticals 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT05262400
What this trial is testing

Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Who this might be right for
Breast CancerSolid Tumors
Pfizer 235
Testing effectiveness (Phase 2)Study completedNCT00788892
What this trial is testing

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
Jazz Pharmaceuticals 126
Early research (Phase 1)Study completedNCT01184092
What this trial is testing

Compare The Amount Of Tasocitinib (CP-690,550) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Three Different Tablet Versions Of Tasocitinib (CP-690,550)

Who this might be right for
Rheumatoid Arthritis
Pfizer 24
Post-approval studies (Phase 4)Study completedNCT02767271
What this trial is testing

Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris

Who this might be right for
Tinea PedisTinea Cruris
Bausch Health Americas, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01576471
What this trial is testing

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo

Who this might be right for
Crohn's Disease
Coronado Biosciences, Inc. 250
Post-approval studies (Phase 4)Study completedNCT00418600
What this trial is testing

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

Who this might be right for
Secondary Hyperparathyroidism
Genzyme, a Sanofi Company 36
Testing effectiveness (Phase 2)Study completedNCT05516407
What this trial is testing

Safety and Efficacy of Oral Full-Spectrum Medicinal Cannabis Plant Extract in Children With Autism Spectrum Disorder.

Who this might be right for
Autism Spectrum Disorder
Fenix Innovation Group 18
Testing effectiveness (Phase 2)Study completedNCT03593200
What this trial is testing

A Phase IIa Study to Assess the Safety, Efficacy, and Pharmacokinetics of Subcutaneously Administered Pegcetacoplan (APL-2) in Subjects With PNH

Who this might be right for
PNH
Apellis Pharmaceuticals, Inc. 4
Large-scale testing (Phase 3)Study completedNCT00751400
What this trial is testing

Naproxen Sodium Extended-Release Actual Use Study

Who this might be right for
Pain
Bayer 497
Post-approval studies (Phase 4)Study completedNCT01129336
What this trial is testing

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

Who this might be right for
First or Second Line HER2-negative Breast CancerMetastatic Disease Without Bone Metastasis
Novartis Pharmaceuticals 44
Early research (Phase 1)Study completedNCT01058707
What this trial is testing

Dose Escalation Study of MLN0128 in Participants With Advanced Malignancies

Who this might be right for
Advanced Solid Malignancies
Millennium Pharmaceuticals, Inc. 198
Large-scale testing (Phase 3)Looking for participantsNCT07325292
What this trial is testing

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 160
Post-approval studies (Phase 4)UnknownNCT01926171
What this trial is testing

Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

Who this might be right for
Non-small-cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 80
Early research (Phase 1)Looking for participantsNCT06997471
What this trial is testing

Phase I Trial on the Safety of Delayed Infusion of a Naïve T Cell-Depleted Hematopoietic Graft With Memory T Cells in Solid Organ Transplant Recipients

Who this might be right for
Solid Organ Transplant ComplicationsSolid Organ Transplant RecipientsSolid Organ Transplant Rejection
Francisco Hernández Oliveros 10
Not applicableStudy completedNCT06556836
What this trial is testing

"Diagnostic Accuracy of Ultrasound Compared to Epidurography for Epidural Catheter Localization"

Who this might be right for
Open Abdominal SurgeryEpidural Analgesia
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 66
Testing effectiveness (Phase 2)Study completedNCT02768207
What this trial is testing

Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
Hoffmann-La Roche 40
Testing effectiveness (Phase 2)Study completedNCT03046992
What this trial is testing

Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC

Who this might be right for
EGFR Gene Mutation
Yuhan Corporation 224
Next Page